MicroRNA-519a demonstrates significant tumour suppressive activity in laryngeal squamous cells by targeting anti-carcinoma HuR gene

Journal of Laryngology and Otology

Volumn 127, Issue 12, 2013, Pages 1194-1202

  Shen, Z ^a   Zhan, G ^b   Deng, H ^a   Ren, Y ^a   Ye, D ^a   Xiao, B ^a   Guo, J ^a  

^a NINGBO UNIVERSITY   (China)

^b Yinzhou No2 Hospital   (China)

Author keywords

HuR Protein; Laryngeal Cancer; MicroRNAs; Squamous Cell Carcinoma

Indexed keywords

HUR PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 519A; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CELLS; DISEASE FREE SURVIVAL; DOWN REGULATION; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MIDDLE AGED; MOLECULAR MECHANICS; MTT ASSAY; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; KAPLAN-MEIER ESTIMATE; LARYNGEAL NEOPLASMS; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84890802703     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215113003174     Document Type: Article

References (35)

1. Jain P, Kumar P, Pai VR, Parikh PM. Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer. Indian J Cancer 2008;45:83-9
2. Micozkadioǧlu D, Unal M, Pata YS, Baştürk M, Cinel L. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in larynx squamous cell carcinoma. Med Sci Monit 2008;14:CR299-304
3. Che XH, Chen H, Xu ZM, Shang C, Sun KL, Fu WN. 14-3-3epsilon contributes to tumour suppression in larynx squamous cell carcinoma by affecting apoptosis and invasion. BMC Cancer 2010;10:306
4. Wang W, Lin P, Han C, Cai W, Zhao X, Sun B. Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma. J Exp Clin Cancer Res 2010;29:60
5. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med (Berl) 2010;88:709-17
6. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 2009;24:652-7
7. Abdelmohsen K, Kim MM, Srikantan S, Mercken EM, Brennan SE, Wilson GM et al. MiR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 2010;9:1354-9
8. Kruys V, Wathelet M, Poupart P, Contreras R, Fiers W, Content J et al. The 3' untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation. Proc Natl Acad Sci U S A 1987;84:6030-4
9. Hackermüller J, Meisner NC, Auer M, Jaritz M, Stadler PF. The effect of RNA secondary structures on RNA-ligand binding and the modifier RNA mechanism: a quantitative model. Gene 2005; 345:3-12
10. López de Silanes I, Zhan M, Lal A, Yang X, Gorospe M. Identification of a target RNA motif for RNA-binding protein HuR. Proc Natl Acad Sci U S A 2004;101:2987-92
11. Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman GA et al. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 2001;108:1657-65
12. López de Silanes I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES et al. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 2003;22:7146-54
13. Cho NP, Han HS, Soh Y, Lee KY, Son HJ. Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas. Pathology 2007;39:545-50
14. Shen Z, Ye D, Zhang X, Jiang Z, Xiao B, Guo J. Inhibitory effect of HuR gene small interfering RNA segment on larynx squamous cell carcinoma Hep-2 cell growth. J Laryngol Otol 2010;124:1183-9
15. Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y et al. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 2009;400:97-102
16. Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D et al. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 2010;45:17-23
17. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97
18. Chekulaeva M, Filipowicz W. Mechanisms of miRNAmediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 2009;21:452-60
19. Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y et al. MicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. Carcinogenesis 2012;33: 220-5
20. Ugras S, Brill E, Jacobsen A, Hafner M, Socci ND, Decarolis PL et al. Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma. Cancer Res 2011;71:5659-69
21. Marasa BS, Srikantan S, Martindale JL, Kim MM, Lee EK, Gorospe M et al. MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging (Albany NY) 2010;2:333-43
22. Abdelmohsen K, Srikantan S, Kuwano Y, Gorospe M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc Natl Acad Sci U S A 2008;105:20297-302
23. Khabar KS. Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci 2010;67:2937-55
24. Abdelmohsen K, Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA 2010;1:214-29
25. Dormoy-Raclet V, Ménard I, Clair E, Kurban G, Mazroui R, Di Marco S et al. The RNA-binding protein HuR promotes cell migration and cell invasion by stabilizing the beta-actin mRNA in a U-rich-element-dependent manner. Mol Cell Biol 2007;27:5365-80
26. Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann Surg Oncol 2007;14: 2738-47
27. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region. J Biol Chem 2000;275:11750-7
28. Ristimäki A, Narko K, Hla T. Down-regulation of cytokineinduced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 1996;318(pt 1):325-31
29. Tong X, Van Dross RT, Abu-Yousif A, Morrison AR, Pelling JC. Apigenin prevents UVB-induced cyclooxygenase 2 expression: coupled mRNA stabilization and translational inhibition. Mol Cell Biol 2007;27:283-96
30. Do SI, Araujo ES, Kalil RK, Bacchini P, Bertoni F, Unni KK et al. Expression of embryonic lethal abnormal vision (ELAV)-like protein HuR and cyclooxygenase-2 (COX-2) in Ewing sarcoma. Tumori 2008;94:347-50
31. Mrena J, Wiksten JP, Thiel A, Kokkola A, Pohjola L, Lundin J et al. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin Cancer Res 2005;11:7362-8
32. Park GB, Song H, Kim YS, Sung M, Ryu JW, Lee HK et al. Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines. Immunology 2009; 128:360-8
33. Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J 2000;19:2340-50
34. Kim HH, Abdelmohsen K, Lal A, Pullmann R Jr, Yang X, Galban S et al. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev 2008;22:1804-15
35. Biggar KK, Storey KB. Perspectives in cell cycle regulation: lessons from an anoxic vertebrate. Curr Genomics 2009;10: 573-84